Article

• • A Howell

  Endocrine prevention of breast cancer: the jury is half in

  Endocr Relat Cancer 5 (4) 249-251, doi:10.1677/erc.0.0050249
  • Full Text (PDF)
• Select this article
  • G D Grossfeld,
  • S W Hayward,
  • T D Tlsty,
  • and G R Cunha

  The role of stroma in prostatic carcinogenesis

  Endocr Relat Cancer 5 (4) 253-270, doi:10.1677/erc.0.0050253
  • Abstract
  • Full Text (PDF)
• Select this article
  • C C Benz

  Transcription factors and breast cancer

  Endocr Relat Cancer 5 (4) 271-282, doi:10.1677/erc.0.0050271
  • Abstract
  • Full Text (PDF)
• Select this article
  • S P Langdon and
  • J F Smyth

  Growth factors and ovarian cancer

  Endocr Relat Cancer 5 (4) 283-291, doi:10.1677/erc.0.0050283
  • Abstract
  • Full Text (PDF)
• Select this article
  • G Scambia,
  • G Ferrandina,
  • G D'Agostino,
  • A Fagotti,
  • M Di Stefano,
  • F Fanfani,
  • F G Serri,
  • and S Mancuso

  Oestrogen and progesterone receptors in ovarian carcinoma

  Endocr Relat Cancer 5 (4) 293-301, doi:10.1677/erc.0.0050293
  • Abstract
  • Full Text (PDF)
• Select this article
  • J Berwaerts,
  • J Verhelst,
  • G Dua,
  • R Abs,
  • I Neetens,
  • and C Mahler

  A pseudo-endocrine suprasellar tumour: review of primitive neuroectodermal tumours in adults

  Endocr Relat Cancer 5 (4) 303-310, doi:10.1677/erc.0.0050303
  • Abstract
  • Full Text (PDF)
• Select this article
  • Gy Liszka,
  • I Számel,
  • I Pete,
  • Á Petrányi,
  • N Udvarhelyi,
  • and B Budai

  Investigation of serum sex hormone levels in postmenopausal patients with multiple benign breast lesions detected by mammography

  Endocr Relat Cancer 5 (4) 311-314, doi:10.1677/erc.0.0050311
  • Abstract
  • Full Text (PDF)
• Select this article
  • C Ferlini,
  • M Di Stefano,
  • M Marone,
  • C Gaggini,
  • G Ferrandina,
  • A Riva,
  • E Bombardelli,
  • A De Pasqua,
  • S Mancuso,
  • and G Scambia

  The synergistic anti-tumour activity of ICI 182,780 in combination with docetaxel is mediated by P-glycoprotein inhibition

  Endocr Relat Cancer 5 (4) 315-324, doi:10.1677/erc.0.0050315
  • Abstract
  • Full Text (PDF)
• • S Leewansangtong and
  • E D Crawford

  Maximal androgen withdrawal for prostate cancer therapy: current status and future potential

  Endocr Relat Cancer 5 (4) 325-339, doi:10.1677/erc.0.0050325
  • Full Text (PDF)
• Select this article
  • F Labrie

  Combined androgen blockade and treatment of localized prostate cancer: a real hope when approaching the year 2000

  Endocr Relat Cancer 5 (4) 341-351, doi:10.1677/erc.0.0050341
  • Abstract
  • Full Text (PDF)
• • L J Denis

  Maximal androgen blockade: facts and fallacies

  Endocr Relat Cancer 5 (4) 353-356, doi:10.1677/erc.0.0050353
  • Full Text (PDF)